Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9261)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 26, 2016 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zahid MF, Parnes A, Savani BN, Litzow MR, Hashmi SK. Therapy-related myeloid neoplasms - what have we learned so far? World J Stem Cells 2016; 8(8): 231-242 [PMID: 27621757 DOI: 10.4252/wjsc.v8.i8.231] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v8/i8/231.htm |
| Number | Citing Articles |
| 1 |
Sang-A Kim, Junshik Hong, Woo Chan Park, Dong-Yeop Shin, Youngil Koh, Inho Kim, Dong Soon Lee, Sung-Soo Yoon, Marina Konopleva. Better treatment outcomes in patients with actively treated therapy-related myeloid neoplasms harboring a normal karyotype. PLOS ONE 2018; 13(12): e0209800 doi: 10.1371/journal.pone.0209800
|
| 2 |
Francesca Roncaglia, Pamela Mancuso, Massimo Vicentini, Antonio Vitiello, Luigi Vecchia, Stefano Luminari, Lucia Mangone, Manuel Zorzi, Carlo La Vecchia, Paolo Giorgi Rossi. New information flows for cancer registries: testing the use of laboratory data in the province of Reggio Emilia, Italy. European Journal of Cancer Prevention 2020; 29(6): 548 doi: 10.1097/CEJ.0000000000000585
|
| 3 |
Naomi D. Atkin, Heather M. Raimer, Zhenjia Wang, Chongzhi Zang, Yuh‐Hwa Wang. Assessing acute myeloid leukemia susceptibility in rearrangement‐driven patients by DNA breakage at topoisomerase II and CCCTC‐binding factor/cohesin binding sites. Genes, Chromosomes and Cancer 2021; 60(12): 808 doi: 10.1002/gcc.22993
|
| 4 |
Anne Calleja, Seongseok Yun, Chimène Moreilhon, Jean Michel Karsenti, Lauris Gastaud, Lionel Mannone, Rami Komrokji, Najla al Ali, Bérangère Dadone‐montaudie, Guillaume Robert, Patrick Auberger, Sophie Raynaud, David A. Sallman, Thomas Cluzeau. Clonal selection in therapy‐related myelodysplastic syndromes and acute myeloid leukemia under azacitidine treatment. European Journal of Haematology 2020; 104(5): 488 doi: 10.1111/ejh.13390
|
| 5 |
Christine Beham-Schmid, Annette Schmitt-Graeff. Bone Marrow Biopsy Pathology. Essentials of Diagnostic Pathology 2020; : 27 doi: 10.1007/978-3-662-60309-3_2
|
| 6 |
M. Chantadisai, H. R. Kulkarni, R. P. Baum. Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival. European Journal of Nuclear Medicine and Molecular Imaging 2021; 48(5): 1390 doi: 10.1007/s00259-020-05127-9
|
| 7 |
Tomáš Szotkowski, Martin Čerňan, Jaromír Hubáček, Milena Holzerová, Tomáš Papajík. Anticancer therapy - related acute myeloid leukemias. Onkologie 2017; 11(3): 115 doi: 10.36290/xon.2017.023
|
| 8 |
Naomi Atkin, Heather Raimer, Yuh-Hwa Wang. Broken by the Cut: A Journey into the Role of Topoisomerase II in DNA Fragility. Genes 2019; 10(10): 791 doi: 10.3390/genes10100791
|
| 9 |
Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang, Roberto N. Miranda. Oncological Surgical Pathology. 2020; : 1729 doi: 10.1007/978-3-319-96681-6_17
|
| 10 |
Uma Borate, Brianna A. Norris, Abby Statler, Rongwei Fu, Taylor Bucy, Mikkael A. Sekeres. Representation of therapy-related myelodysplastic syndrome in clinical trials over the past 20 years. Blood Advances 2019; 3(18): 2738 doi: 10.1182/bloodadvances.2019000293
|